<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03497026</url>
  </required_header>
  <id_info>
    <org_study_id>DD082015</org_study_id>
    <nct_id>NCT03497026</nct_id>
  </id_info>
  <brief_title>Auris Robotic Endoscopy System for Bronchoscopy</brief_title>
  <official_title>A Single-Center, Prospective, Single Arm Study to Evaluate the Performance of the Auris Robotic Endoscopy System for Bronchoscopic Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Auris Health, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Auris Health, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the performance related to the use of the novel Robotic Endoscopy Platform&#xD;
      during bronchoscopic procedures will be evaluated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The early and accurate diagnosis of lung cancer is critical. However, many peripheral lung&#xD;
      lesions are beyond the reach of conventional bronchoscopes. Additionally, alternative&#xD;
      techniques, such as CT-guided or surgical biopsy, can carry increased risks to the patient.&#xD;
      Diagnostic yield of flexible bronchoscopy is limited by its inability to guide biopsy&#xD;
      instruments directly to the lesion. Varying technologies have been proposed to guide&#xD;
      endobronchial biopsies, such as electromagnetic navigation, endobronchial ultrasound (EBUS)&#xD;
      and computed tomography fluoroscopy. However, the correlation of real-time guidance and the&#xD;
      ability to precisely direct a biopsy instrument is critical to biopsy success.&#xD;
&#xD;
      In this study , the novel Robotic Endoscopy Platform and its accessories will be used to&#xD;
      provide bronchoscopic visualization of and access to patient airways for diagnostic&#xD;
      procedures. Commercially available biopsy instruments will be used to acquire tissue for&#xD;
      diagnostic purposes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Mutual Termination&#xD;
  </why_stopped>
  <start_date type="Actual">March 30, 2018</start_date>
  <completion_date type="Actual">July 10, 2018</completion_date>
  <primary_completion_date type="Actual">July 10, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Who Completed the Intended Bronchoscopic Procedure With the Robotic Endoscopy Platform</measure>
    <time_frame>During the procedure, up to 2 hours</time_frame>
    <description>Completion of the intended bronchoscopic procedure is defined by the ability to acquire tissue with biopsy tools.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Robotic Bronchoscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Robotic bronchoscopy with Robotic Bronchoscopy Platform</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Robotic Bronchoscopy Platform</intervention_name>
    <description>Eligible patients will undergo the robotic bronchoscopy for evaluation of suspected lung nodules.</description>
    <arm_group_label>Robotic Bronchoscopy</arm_group_label>
    <other_name>The Monarch Platform</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 18 to 80 years of age;&#xD;
&#xD;
          2. Capable and willing to give informed consent;&#xD;
&#xD;
          3. Acceptable candidate for an elective, non-emergent bronchoscopic procedure;&#xD;
&#xD;
          4. Solid peripheral lung lesions suspected of malignancy, between 1.5-7cm in size&#xD;
             identified on thin slice CT scan with 30 days of the intended bronchoscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Medical contraindication to bronchoscopy;&#xD;
&#xD;
          2. Ground glass opacity lesions on pre-procedure CT&#xD;
&#xD;
          3. Participation in any other clinical trial 30 days before and throughout the duration&#xD;
             of the study;&#xD;
&#xD;
          4. Uncontrolled or irreversible coagulopathy;&#xD;
&#xD;
          5. Female subjects who are pregnant or nursing or those of child-bearing potential&#xD;
             refusing a pregnancy test;&#xD;
&#xD;
          6. CT scan done over a month before the bronchoscopy procedure.&#xD;
&#xD;
        Intra-Procedure Exclusion Criteria: Any presenting condition discovered intra-procedurally&#xD;
        that in the opinion of the investigator would make participating in this study not in the&#xD;
        patient's best interest.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ganesh Krishna, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>El Camino Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>El Camino Hospital</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <zip>94040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Palo Alto Medical Foundation Mountain View Center</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <zip>94040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 6, 2018</study_first_submitted>
  <study_first_submitted_qc>April 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2018</study_first_posted>
  <results_first_submitted>September 22, 2021</results_first_submitted>
  <results_first_submitted_qc>October 18, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">November 15, 2021</results_first_posted>
  <last_update_submitted>October 18, 2021</last_update_submitted>
  <last_update_submitted_qc>October 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 5, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/26/NCT03497026/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Robotic Bronchoscopy</title>
          <description>Robotic bronchoscopy with Robotic Bronchoscopy Platform&#xD;
Robotic Bronchoscopy Platform: Eligible patients will undergo the robotic bronchoscopy for evaluation of suspected lung nodules.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Robotic Bronchoscopy</title>
          <description>Robotic bronchoscopy with Robotic Bronchoscopy Platform&#xD;
Robotic Bronchoscopy Platform: Eligible patients will undergo the robotic bronchoscopy for evaluation of suspected lung nodules.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Completed the Intended Bronchoscopic Procedure With the Robotic Endoscopy Platform</title>
        <description>Completion of the intended bronchoscopic procedure is defined by the ability to acquire tissue with biopsy tools.</description>
        <time_frame>During the procedure, up to 2 hours</time_frame>
        <population>due to termination after 4 subjects enrolled, no statistical analyses would have been performed or would be considered scientifically appropriate.</population>
        <group_list>
          <group group_id="O1">
            <title>Robotic Bronchoscopy</title>
            <description>Robotic bronchoscopy with Robotic Bronchoscopy Platform&#xD;
Robotic Bronchoscopy Platform: Eligible patients will undergo the robotic bronchoscopy for evaluation of suspected lung nodules.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Completed the Intended Bronchoscopic Procedure With the Robotic Endoscopy Platform</title>
          <description>Completion of the intended bronchoscopic procedure is defined by the ability to acquire tissue with biopsy tools.</description>
          <population>due to termination after 4 subjects enrolled, no statistical analyses would have been performed or would be considered scientifically appropriate.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>from enrollment through patient follow-up; 6 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Robotic Bronchoscopy</title>
          <description>Robotic bronchoscopy with Robotic Bronchoscopy Platform&#xD;
Robotic Bronchoscopy Platform: Eligible patients will undergo the robotic bronchoscopy for evaluation of suspected lung nodules.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>hospital admission for planned surgery</sub_title>
                <description>planned hospital admission</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>coughing</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>sore throat</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>wheezing</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Study mutually terminated, no data analyzed</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Scott Rehage</name_or_title>
      <organization>Auris Health</organization>
      <phone>925 6832590</phone>
      <email>srehage@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

